TRIGZALTO Trademark

Trademark Overview

On Thursday, January 20, 2022, a trademark application was filed for TRIGZALTO with the United States Patent and Trademark Office. The USPTO has given the TRIGZALTO trademark a serial number of 97229959. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, September 11, 2024. This trademark is owned by AstraZeneca AB. The TRIGZALTO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines
trigzalto

General Information

Serial Number97229959
Word MarkTRIGZALTO
Filing DateThursday, January 20, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, September 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 2, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Wednesday, March 2, 2022NON-FINAL ACTION E-MAILED
Monday, January 24, 2022NEW APPLICATION ENTERED
Tuesday, January 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 2, 2022ASSIGNED TO EXAMINER
Wednesday, March 2, 2022NON-FINAL ACTION WRITTEN
Wednesday, March 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 27, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 27, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 27, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 29, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 2, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 13, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 2, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 14, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 14, 2023SOU EXTENSION 1 FILED
Tuesday, March 14, 2023SOU EXTENSION 1 GRANTED
Monday, September 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 11, 2024SOU TEAS EXTENSION RECEIVED
Monday, March 11, 2024SOU EXTENSION 3 FILED
Monday, March 11, 2024SOU EXTENSION 3 GRANTED
Tuesday, March 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 11, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 11, 2024SOU EXTENSION 4 GRANTED
Wednesday, September 11, 2024SOU EXTENSION 4 FILED
Monday, September 18, 2023SOU EXTENSION 2 FILED
Monday, September 18, 2023SOU EXTENSION 2 GRANTED
Wednesday, September 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

trigzalto pharmaceutical substances preparations disorders diseases treatment infection hematological inflammation autoimmune